Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03268278 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
A Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT03268278 is a Phase 1 study that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT03268278, a Phase 1 study, was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
To see whether the addition of buprenorphone to local anesthesia will lengthen postoperative analgesia for endodontic pain
Interventions
- DRUG Buprenorphine
- DRUG Sterile saline
- DRUG lidocaine, epinephrine (Local anesthetic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2018-07-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03268278
The ClinicalTrials.gov registry entry for NCT03268278 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Buprenorphine is the first listed.
NCT03268278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03268278 about?
NCT03268278 is a clinical study titled "Efficacy of Buprenorphine on Postoperative Endodontic Analgesia". To see whether the addition of buprenorphone to local anesthesia will lengthen postoperative analgesia for endodontic pain
What is the current status of trial NCT03268278?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2017-04-01. Estimated completion is 2018-07-01.
What interventions are being tested in trial NCT03268278?
The interventions under investigation include: Buprenorphine (DRUG), Sterile saline (DRUG), lidocaine, epinephrine (Local anesthetic) (DRUG).
Who is sponsoring clinical trial NCT03268278?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.